3 news items
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
PRLD
7 May 24
and commercialization of product candidates, clinical trial sites and our ability to enroll eligible patients, supply chain and manufacturing facilities, Prelude's
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
PRLD
9 Apr 24
of product candidates, clinical trial sites and our ability to enroll eligible patients, supply chain and manufacturing facilities, Prelude's ability
Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting
PRLD
5 Mar 24
, clinical trial sites and our ability to enroll eligible patients, supply chain and manufacturing facilities, Prelude's ability to maintain
- Prev
- 1
- Next